PlainRecalls
FDA Drug Moderate Class II Terminated

ONDANSETRON INJECTION, USP, 4 mg/ 2 mL (2 mg/mL), For IM or IV Use, Single Dose 2 mL Vials, Rx only. APP Pharmaceuticals, LLC, Schaumburg, IL 60173. NDC: 63323-373-02

Reported: December 17, 2014 Initiated: September 27, 2012 #D-0296-2015

Product Description

ONDANSETRON INJECTION, USP, 4 mg/ 2 mL (2 mg/mL), For IM or IV Use, Single Dose 2 mL Vials, Rx only. APP Pharmaceuticals, LLC, Schaumburg, IL 60173. NDC: 63323-373-02

Reason for Recall

Lack of Assurance of Sterility: Glass vials may have finish fractures and glass particles.

Details

Recalling Firm
Fresenius Kabi USA, LLC
Units Affected
184,550 Vials
Distribution
U.S. Nationwide Including Puerto Rico
Location
Lake Zurich, IL

Frequently Asked Questions

What product was recalled?
ONDANSETRON INJECTION, USP, 4 mg/ 2 mL (2 mg/mL), For IM or IV Use, Single Dose 2 mL Vials, Rx only. APP Pharmaceuticals, LLC, Schaumburg, IL 60173. NDC: 63323-373-02. Recalled by Fresenius Kabi USA, LLC. Units affected: 184,550 Vials.
Why was this product recalled?
Lack of Assurance of Sterility: Glass vials may have finish fractures and glass particles.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 17, 2014. Severity: Moderate. Recall number: D-0296-2015.